London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M (Ingrid Lunden/TechCrunch)

Elena Posted by — July 14, 2023 in Tech News —

Ingrid Lunden / TechCrunch:
London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M  —  Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery.

You May Also Like

Critics say FTC Chair Lina Khan’s take-it-to-the-courts strategy is flawed, ahead of a House Judiciary Committee hearing to “examine mismanagement of the FTC” (Cecilia Kang/New York Times)

A California law firm launches a class-action suit against Google, alleging user data scraping sans consent for AI training, after a similar suit against OpenAI (Catherine Thorbecke/CNN)

Twitter’s best defense against Threads may be to refocus on news and reactions from people you follow, leaving growth via algorithmic feeds to Threads (Ben Thompson/Stratechery)

Collective, a financial management service for freelancers offering bookkeeping, payroll, and tax tools, raised $50M, bringing its total funding to $82M (Kyle Wiggers/TechCrunch)

Elena

About the Author: Elena

Elena Tsai is an Online Marketing Expert, Premier Google Partner. In addition to being the founder of this website, Elena is also an interactive and SEO Specialist with 5 years of experience who is available for freelance and full-time work.